Cardio Diagnostics Holdings EBIT

The latest EBIT for CDIO is $-63K as of June 2026. That compares with $-6.3M in the prior-year period — up 99.0% year over year. That is above the sector sector average of $-6.4M. Investors often review this figure alongside Cardio Diagnostics Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, CDIO's EBIT moved from $-6.3M to $-63K — a 99.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cardio Diagnostics Holdings's operating scale or balance-sheet position.

Against its sector companies, CDIO currently prints $-63K for EBIT, while the sector average sits near $-6.4M. That is roughly 99.0% above the sector mean. Large gaps often invite a closer look at Cardio Diagnostics Holdings's growth, margins, and balance sheet.

A EBIT figure of $-63K for CDIO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.

After noting CDIO's EBIT ($-63K), review year-over-year change from $-6.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.